Executive Board members Dr. Gunnar Wiedenfels and Dr. Ralf Schremper also have performance share units from work performed before they joined the Executive Board. These were not granted as remuneration for their role on the Executive Board and are thus not included in the overview. Executive Board members Dr. Gunnar Wiedenfels, Dr. Ralf Schremper and Jan David Frouman also have stock options from work performed before they joined the Executive Board. These were not granted as remuneration for their role on the Executive Board and are thus not included in the overview. All stock options have now been exercised or redeemed.

To settle incentives for work performed before joining the Executive Board, Christof Wahl was allocated a one-off additional amount of 24,000 performance share units in the financial year 2016.

Axel Salzmann left the Executive Board effective March 31, 2015. Information on share-based payment instruments in his case can be found in the chapter regarding total compensation of former members of the Executive Board.

Nominal amounts of performance share units when granted.

Dr. Gunnar Wiedenfels will leave the Executive Board as of March 31, 2017. In accordance with the terms and conditions of the plan, performance shares units that have not been vested expire on the termination date. In addition, the termination agreement of Dr. Gunnar Wiedenfels stipulates that vested performance share units are to be settled in cash when he leaves the Company. Dr. Christian Wegner stepped down from the Executive Board as of December 31, 2016. Dr. Christian Wegner’s termination agreement stipulates that he is still participating in the Group Share Plan in accordance with the terms and conditions of the plan with the performance share units issued until the termination date, on the condition that with regard of the vesting of these the original termination of the employment contract is assumed (December 31, 2017). The unaffected portion of performance share units expired in the financial year 2016.

The total cost in the financial year 2016 includes an adjustment of the conversion factor for the performance shares granted (107.6 %) for the Group Share Plan 2013 and was measured as of December 31, 2016. No adjustments were made due to anti-dilution protection or an individual increase by the Supervisory Board.
In addition to adjustments to performance share units granted for anti-dilution protection for a superdividend (1.23) and to the conversion factor (102.7 %), the total cost for the financial year 2015 also includes the individual increase by the Supervisory Board (17.5 %) measured as of December 31, 2015.